Remedy for diagnostic of tick-borne borreliosis (Lyme disease) - analogs
Pharmgroups: Immunobiological diagnostic tools |
|||||||||
| Prices in pharmacies: Instructions Remedy for diagnostic of tick-borne borreliosis (Lyme disease) | |||||||||
|
ⓘ✘Enter drugs for checking interactions through a quick button search . Bromdihydrochlorphenylbenzodiazepine ✘ (incl) Zopiclone ✘ |
|
ⓘ✘ diseases to evaluate contraindications and side effects through a quick search. | ||||||
Начиная работу с сервисом, вы принимаете соглашение пользователя. Kiberis do not replace the doctor!
- 30% Leflunomide neutral
- 24% Ixekizumab neutral
- 20% Ustekinumab neutral
- 20% Comari palustri rhizomatum tinctura neutral
- 15% Risankizumab neutral
- 13% Sulfinpyrazone neutral
- 12% Olokizumab No 🔍
- 12% Upadacitinib neutral
- 12% Sarilumab neutral
- 11% Benzbromarone neutral
- 11% Netakimab neutral
- 10% Rubiae tinctori rhizomatum cum radicibus extract neutral
- 10% Methylsalicylate neutral
- 10% Tofacitinib neutral
- 10% Nabumetone neutral
- 10% Fenoprofen neutral
- 10% Methenamine neutral
- 10% Sodium citrate neutral
- 10% Menthol+Methylsalycilate neutral [Methylsalicylate]
- 10% Uvae ursi folia neutral
- 10% Carbomer neutral
- 10% Belimumab neutral
- 10% Uvae ursi foliae extract neutral
Learn more about the selection of analogues
- The drug has «Remedy for diagnostic of tick-borne borreliosis (Lyme disease)» no complete analogues; 24 analogs by action, the most similar - Leflunomide .
- Medical online service has selected the best substitutes for Remedy for diagnostic of tick-borne borreliosis (Lyme disease) based on its instructions, components, pharmaceutical groups and practical application.
- The table shows the prices of analogues Remedy for diagnostic of tick-borne borreliosis (Lyme disease) to choose the cheapest pills.
- If you have introduced other drugs for registration, substitutes are selected taking into account the assessment of interactions and safety.
- Sometimes, due to the presence of dangerous interactions, it is necessary to use drugs that are similar in effect, sometimes even from different pharmacological groups.